MTLS

Materialise NV

MTLS.US materialise.com
7.63
+0.20 (+2.69%)
USD · NASDAQ
52-week range
4.78
7.72
Trading at 97% of the 52-week range
Market Cap
429.36M
P/E Ratio
27.52
Forward P/E
625.00
Book Value
5.11
Div. Yield
N/A
% Institutions
14.25%
% Insiders
5.31%

1 Year

+46.9%

3 Year

+25.0%

10 Year

+4.8%
Description

Materialise NV provides additive manufacturing and medical software tools, and 3D printing services in the Americas, Europe, Africa, and the Asia-Pacific. The company operates through three segments: Materialise Software, Materialise Medical, and Materialise Manufacturing. The Materialise Software segment offers proprietary software through programs and platforms that enable and enhance the functionality of 3D printers, and printing operations. Its software interfaces between various types of 3D printers; and various software applications and capturing technologies, including computer-aided design/computer-aided manufacturing packages and 3D scanners; a MES, software providers. This segment serves 3D printing machine manufacturers; production companies and contract manufacturers in automotive, aerospace, consumer goods, and hearing aid industries; and 3D printing service bureaus through its sales force, website, and third-party distributors. The Materialise Medical segment provides medical software that allows medical-image based analysis, planning, and engineering, as well as patient-specific design and printing of surgical devices and implants. It serves medical device companies, hospitals, universities, research institutes, and industrial companies. The Materialise Manufacturing segment provides 3D printing services, design and engineering services, and rapid prototyping and additive manufacturing of production parts to customers serving the automotive, consumer goods industrial goods, semiconductor, art and architecture and aerospace markets. The company has collaboration agreements with Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Limacorporate Spa; Mathys AG; Smith & Nephew Inc.; Corin Ltd; Medtronic Inc.; and Abbott Laboratories Inc. Materialise NV was incorporated in 1990 and is headquartered in Leuven, Belgium.

Company Information

Company Name
Materialise NV
Sector
Technology
Industry
Software - Application
Exchange
NASDAQ
ISIN: US57667T1007
CIK: 0001091223
CUSIP: 57667T100
Currency: USD
Full Time Employees: 2,556
Phone: 32 1 639 66 11
Fiscal Year End: December
IPO Date: Jun 25, 2014
Description:

Materialise NV provides additive manufacturing and medical software tools, and 3D printing services in the Americas, Europe, Africa, and the Asia-Pacific. The company operates through three segments: Materialise Software, Materialise Medical, and Materialise Manufacturing. The Materialise Software segment offers proprietary software through programs and platforms that enable and enhance the functionality of 3D printers, and printing operations. Its software interfaces between various types of 3D printers; and various software applications and capturing technologies, including computer-aided design/computer-aided manufacturing packages and 3D scanners; a MES, software providers. This segment serves 3D printing machine manufacturers; production companies and contract manufacturers in automotive, aerospace, consumer goods, and hearing aid industries; and 3D printing service bureaus through its sales force, website, and third-party distributors. The Materialise Medical segment provides medical software that allows medical-image based analysis, planning, and engineering, as well as patient-specific design and printing of surgical devices and implants. It serves medical device companies, hospitals, universities, research institutes, and industrial companies. The Materialise Manufacturing segment provides 3D printing services, design and engineering services, and rapid prototyping and additive manufacturing of production parts to customers serving the automotive, consumer goods industrial goods, semiconductor, art and architecture and aerospace markets. The company has collaboration agreements with Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Limacorporate Spa; Mathys AG; Smith & Nephew Inc.; Corin Ltd; Medtronic Inc.; and Abbott Laboratories Inc. Materialise NV was incorporated in 1990 and is headquartered in Leuven, Belgium.

Address:

Technologielaan 15, Leuven, Belgium, 3001

People

Directors & Officers

Name Title Year Born
Mr. Wilfried Vancraen Founder & Chairman 1962
Ms. Brigitte de Vet-Veithen Chief Executive Officer 1972
Mr. Koen Berges Chief Financial Officer 1976
Mr. Johan Pauwels Executive VP & COO 1968
Mr. Bart Van der Schueren Chief Strategy & Technology Officer and Executive VP 1968
Ms. Carla Van Steenbergen Executive Vice President, Director of Corporate Affairs, Compliance Officer & Secretary 1977
Ms. Valérie Nerinckx Interim HR Director & CHRO NA
Mr. Jurgen Laudus Executive Vice President of Manufacturing 1979
Mr. Udo Eberlein Executive Vice President of Software 1969
Mr. Koen Peters Executive Vice President of Medical 1978

Shareholders

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Disciplined Growth Investors Inc 1.99M Jun 30, 2026 3.44% $0.25 75.49%
Rock Point Advisors, LLC 990.87K Jun 30, 2026 1.71% $1.80 -2.42%
Archon Capital Management LLC 766.62K Jun 30, 2026 1.32% $2.31 3.22%
King Luther Capital Management Corp 628.75K Mar 31, 2026 1.09% $0.01 0.00%
Acadian Asset Management LLC 552.72K Mar 31, 2026 0.96% $0.00 0.00%
ARK Investment Management LLC 444.32K Mar 31, 2026 0.77% $0.02 -9.86%
Wells Fargo & Co 356.02K Mar 31, 2026 0.62% $0.00 6.22%
Arrowstreet Capital Limited Partnership 342.64K Mar 31, 2026 0.59% $0.00 -4.55%
Renaissance Technologies Corp 304.70K Mar 31, 2026 0.53% $0.00 -0.55%
Morgan Stanley - Brokerage Accounts 206.35K Mar 31, 2026 0.36% $0.00 73.57%
Edmond de Rothschild Holding S.A. 200.01K Jun 30, 2026 0.35% $0.02 0.00%
Citadel Advisors Llc 197.62K Mar 31, 2026 0.34% $0.00 12.73%
Crédit Agricole S.A. 196.95K Mar 31, 2026 0.34% $0.00 -55.93%
Susquehanna International Group, LLP 161.31K Mar 31, 2026 0.28% $0.00 79.18%
Two Sigma Investments LLC 107.98K Mar 31, 2026 0.19% $0.00 148.84%
NANO CAP NEW MILLENNIUM GROWTH FUND L P 100.00K Mar 31, 2026 0.17% $0.46 0.00%
Quinn Opportunity Partners LLC 80.00K Jun 30, 2026 0.14% $0.03 0.00%
XTX Topco Ltd 67.40K Mar 31, 2026 0.12% $0.01 35.03%
Millennium Management LLC 67.30K Jun 30, 2026 0.12% $0.00 18.33%
UBS Group AG 61.53K Mar 31, 2026 0.11% $0.00 61.31%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Disciplined Growth - Small Cap Growth 1.51M 2.62% ▲ 104.18% Jun 30, 2026
2 DGI Small Cap Fund R1 480.90K 0.83% ▲ 86.17% Jun 30, 2026
3 The 3D Printing ETF 342.12K 0.59% ▲ 0.00% Aug 31, 2026
4 EdR SICAV Tech for Tomorrow CR EUR 200.08K 0.35% ▼ 0.00% Jul 31, 2026
5 Paladin One F 174.41K 0.30% ▲ 0.02% Jul 31, 2026
6 WertArt Capital Fonds AMI I (a) 90.00K 0.16% ▲ 0.00% Aug 31, 2026
7 Pacer BlueStar Engineering the Fut ETF 43.57K 0.08% ▲ 0.00% Aug 31, 2026
8 ActivePassive International Equity ETF 32.11K 0.06% ▲ 0.00% Aug 31, 2026
9 State Street® SPDR® S&P® Intl Sm Cp ETF 21.65K 0.04% ▲ 0.00% Aug 31, 2026
10 Fidelity Nasdaq Composite Index 18.53K 0.03% ▲ 0.00% Jul 31, 2026

Financial Highlights

Market Cap: $429.36M
EBITDA: $26.73M
P/E Ratio: $27.52
PEG Ratio: $1.26
Book Value: $5.11
Earnings/Share: $0.27
Profit Margin: 4.84%
Operating Margin: 0.61%
ROA (TTM): 1.65%
ROE (TTM): 5.22%
Revenue (TTM): $272.77M
Revenue/Share (TTM): $4.64
Earnings Growth (YOY): 1,595.60%
Revenue Growth (YOY): 8.10%

Valuation Metrics

Enterprise Value: $353.79M
Trailing P/E: 27.52
Forward P/E: 625.00

Shares Statistics

Shares Outstanding: 57.79M
Shares Float: 23.28M
% Insiders: 5.31%
% Institutions: 14.25%
Short % Float: 1.38%

Stock Price History

1 Year Price History

3 Years Price History

10 Years Price History

Financial Charts

Revenue, Net Income & Operating Cash Flow (Yearly)

Revenue, Net Income & Operating Cash Flow (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

Open full waterfall
Line Item
Step Type
Value
Revenue
adjust
$257.07M
Cost of Goods Sold
adjust
$-110.16M
Gross Profit
subtotal
$146.91M
SG&A
adjust
$-85.51M
R&D
adjust
$-44.27M
Other Operating Expense
adjust
$-12.19M
Operating Income
subtotal
$4.94M
Other / Non-Operating Items
adjust
$2.47M
Net Income
subtotal
$7.41M

Earnings Per Share (EPS) History

Financial Ratios

📦 Raw API Data (JSON Explorer)

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about MTLS.US!